Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott J Spencer

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Journal of Managed Care & Specialty Pharmacy|July 27, 2019
Consideration for Employer-Based and Geographic Attributes Included in Value Assessment Methods of Next-Generation Sequencing TestsM Ragan Hart, Scott J Spencer
Frontiers in Genetics|October 21, 2022
Population genomic screening: Ethical considerations to guide age at implementationScott J Spencer, Stephanie M Fullerton
Journal of Managed Care & Specialty Pharmacy|February 15, 2021
Cost-effectiveness of obinutuzumab versus rituximab biosimilars for previously untreated follicular lymphomaScott J Spencer, Gregory F Guzauskas, Federico FeLizzi, et al.
Journal of Clinical Lipidology|August 12, 2022
Cost-effectiveness of population-wide genomic screening for familial hypercholesterolemia in the United StatesScott J Spencer, Laney K Jones, Gregory F Guzauskas, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|March 1, 2022
Cost-effectiveness of population-wide genomic screening for Lynch syndrome in the United StatesGregory F Guzauskas, Shangqing Jiang, Shawn Garbett, et al.
JAMA Network Open|October 29, 2020
Cost-effectiveness of Population-Wide Genomic Screening for Hereditary Breast and Ovarian Cancer in the United StatesGregory F Guzauskas, Shawn Garbett, Zilu Zhou, et al.
Annals of Internal Medicine|May 8, 2023
Population Genomic Screening for Three Common Hereditary Conditions : A Cost-Effectiveness AnalysisGregory F Guzauskas, Shawn Garbett, Zilu Zhou, et al.
Circulation. Genomic and Precision Medicine|July 21, 2022
Impact of a Population Genomic Screening Program on Health Behaviors Related to Familial Hypercholesterolemia Risk ReductionLaney K Jones, Nan Chen, Dina A Hassen, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Journal of Managed Care & Specialty Pharmacy|July 27, 2019
Consideration for Employer-Based and Geographic Attributes Included in Value Assessment Methods of Next-Generation Sequencing TestsM Ragan Hart, Scott J Spencer
Frontiers in Genetics|October 21, 2022
Population genomic screening: Ethical considerations to guide age at implementationScott J Spencer, Stephanie M Fullerton
Journal of Managed Care & Specialty Pharmacy|February 15, 2021
Cost-effectiveness of obinutuzumab versus rituximab biosimilars for previously untreated follicular lymphomaScott J Spencer, Gregory F Guzauskas, Federico FeLizzi, et al.
Journal of Clinical Lipidology|August 12, 2022
Cost-effectiveness of population-wide genomic screening for familial hypercholesterolemia in the United StatesScott J Spencer, Laney K Jones, Gregory F Guzauskas, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|March 1, 2022
Cost-effectiveness of population-wide genomic screening for Lynch syndrome in the United StatesGregory F Guzauskas, Shangqing Jiang, Shawn Garbett, et al.
JAMA Network Open|October 29, 2020
Cost-effectiveness of Population-Wide Genomic Screening for Hereditary Breast and Ovarian Cancer in the United StatesGregory F Guzauskas, Shawn Garbett, Zilu Zhou, et al.
Annals of Internal Medicine|May 8, 2023
Population Genomic Screening for Three Common Hereditary Conditions : A Cost-Effectiveness AnalysisGregory F Guzauskas, Shawn Garbett, Zilu Zhou, et al.
Circulation. Genomic and Precision Medicine|July 21, 2022
Impact of a Population Genomic Screening Program on Health Behaviors Related to Familial Hypercholesterolemia Risk ReductionLaney K Jones, Nan Chen, Dina A Hassen, et al.
Pageof 1